1239711-35-3

Upstream product

• 1239711-17-1 tert-butyl 2-(7-(4-methoxy-2,6-dimethylphenylsulfon-amido)-1H-indol-1-yl)acetate 

Downstream Products

• 1239709-39-7 4-methoxy-2,6-dimethyl-N-[1-[2-oxo-2-[4-pyridin-3-yl-4-(2-pyrrolidin-1-yl-ethoxy)piperidin-1-yl]ethyl]-1H-indol-7-yl]benzenesulfonic acid amide 
• 1239709-38-6 4-methoxy-2,6-dimethyl-N-[1-[2-oxo-2-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecan-3-yl)ethyl]-1H-indol-7-yl]benzenesulfonic acid amide 
• 1239709-35-3 4-methoxy-2,6-dimethyl-N-[1-[2-oxo-2-(4-pyridin-4-yloxy-piperidin-1-yl)ethyl]-1H-indol-7-yl]benzenesulfonic acid amide 

Relevant academic research and scientific papers

Substituted Indole Compounds

Substituted indole compounds corresponding to the formula I: In which R8, R9a, R9b, R10, R11, R200, R210, A, D, T, q, s and t have defined meanings, processes for the preparation thereof, pharmaceutical compositions containing such compounds and the use of substituted indole compounds for the treatment or inhibition of pain and other conditions which are at least partly mediated by Bradykinin 1 receptors (B1R).